Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines Agency

Gland Pharma gets 3 USFDA observations for Visakhapatnam facility

Written By Ruchika Sharma26 Feb 2025 11:30 AM IST

Hyderabad: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded an inspection with three observations...

GSK buys IDRx for up to USD 1.15 billion

Written By Ruchika Sharma25 Feb 2025 2:33 PM IST

London: GSK plc has announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated...

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon Biologics unveils Yesintek biosimilar to Stelara in US

Written By Ruchika Sharma25 Feb 2025 12:31 PM IST

YESINTEK will be available in all the same formulations currently provided by Stelara.

CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule Approval

Takeda gets EMA nod for additional subcutaneous administration of Takhzyro in Hereditary Angioedema patients

Written By Ruchika Sharma25 Feb 2025 10:30 AM IST

Zurich: Takeda has announced that the European Medicines Agency (EMA) has given approval for an additional 2 mL pre-filled pen option for...

Cipla, Hetero win bid to supply widely prescribed diabetes drug in China

DCGI bans production, export of all combinations of tapentadol, carisoprodol

Written By Ruchika Sharma24 Feb 2025 5:48 PM IST

New Delhi: Acting on recent reports regarding the export of unapproved combination drugs containing Tapentadol and Carisoprodol, the...

Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation

Senores Pharma buys USFDA approved ANDA for COPD drug

Written By Ruchika Sharma24 Feb 2025 1:30 PM IST

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has signed an agreement to...

Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035

Syngene International gets 5 USFDA observations for Bengaluru facilities

Written By Ruchika Sharma24 Feb 2025 11:30 AM IST

Bengaluru: Syngene International has announced that the U.S. Food and Drugs Administration (USFDA) has concluded the inspection with five...

USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XR

Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals

Written By Ruchika Sharma23 Feb 2025 3:30 PM IST

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing...

GSK Nucala application for COPD accepted for review in China

Written By Ruchika Sharma23 Feb 2025 12:30 PM IST

GSK plc has announced that the China National Medical Products Administration has accepted for review the new drug application for the use of...

Global Fund expands commitment to improve access to HIV drug

Gilead Seladelpar gets Conditional European Marketing Authorization for Primary Biliary Cholangitis

Written By Ruchika Sharma23 Feb 2025 11:30 AM IST

Foster City: Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment...

Zydus Lifesciences Slapped Rs 1.42 Crore Tax Demand, Plans to Challenge Order

Zydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis

Written By Ruchika Sharma22 Feb 2025 4:26 PM IST

Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug Administration...

Lupin Launches Dasatinib in US Market in Partnership with Pharmascience

USFDA issues EIR for Lupin Somerset facility

Written By Ruchika Sharma22 Feb 2025 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has issued the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok